Needham & Company LLC restated their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a research report released on Tuesday,Benzinga reports. Needham & Company LLC currently has a $6.00 price objective on the stock. TSHA has been the topic of a number of other research reports. Chardan Capital reaffirmed a […]

Genius Sports (NYSE:GENI – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $9.00 price objective on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 11.39% from […]

Needham & Company LLC reaffirmed their buy rating on shares of CompoSecure (NASDAQ:CMPO – Free Report) in a report issued on Monday morning,Benzinga reports. Needham & Company LLC currently has a $16.00 price objective on the stock. A number of other equities analysts also recently commented on the company. Lake Street Capital lifted their target […]

Fortinet (NASDAQ:FTNT – Get Free Report)‘s stock had its “hold” rating reissued by Needham & Company LLC in a report issued on Monday,Benzinga reports. Several other research analysts have also weighed in on the company. Piper Sandler lifted their price objective on Fortinet from $70.00 to $80.00 and gave the stock a “neutral” rating in […]

Perion Network (NASDAQ:PERI – Get Free Report)‘s stock had its “hold” rating reiterated by research analysts at Needham & Company LLC in a report released on Thursday,Benzinga reports. Other analysts also recently issued reports about the company. Stifel Nicolaus decreased their target price on Perion Network from $9.00 to $7.50 and set a “hold” rating […]

Needham & Company LLC reissued their hold rating on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report sent to investors on Friday,Benzinga reports. Several other research firms also recently issued reports on MRNA. Barclays decreased their price objective on shares of Moderna from $155.00 to $125.00 and set an “overweight” rating for […]

Zillow Group (NASDAQ:Z – Get Free Report)‘s stock had its “hold” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Thursday,Benzinga reports. Several other equities research analysts have also commented on Z. Craig Hallum upgraded shares of Zillow Group to a “strong-buy” rating in a research note […]

Needham & Company LLC restated their buy rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note released on Thursday morning,Benzinga reports. The brokerage currently has a $205.00 target price on the biotechnology company’s stock. Several other research firms have also issued reports on SRPT. Piper Sandler dropped their price target […]

Needham & Company LLC reissued their hold rating on shares of Cardlytics (NASDAQ:CDLX – Free Report) in a report published on Thursday morning,Benzinga reports. A number of other brokerages have also commented on CDLX. Bank of America lowered Cardlytics from a “neutral” rating to an “underperform” rating and dropped their price target for the stock […]

Needham & Company LLC restated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $60.00 target price on the stock. A number of other brokerages also recently weighed in on IONS. Leerink Partnrs raised shares of Ionis Pharmaceuticals from […]